Comparison of efficacy of conbercept, aflibercept, and ranibizumab ophthalmic injection in the treatment of macular edema caused by retinal vein occlusion: a Meta-analysis [PDF]
International Journal of Ophthalmology, 2023 AIM: To evaluate and compare the anatomical and functional outcomes and negative effects of the three anti-vascular endothelial growth factor (VEGF) drugs in the treatment of macular edema (ME) due to retinal vein occlusion (RVO) based on the evidence ...
Qiu Xing +3 more
doaj +3 more sources
Aqueous Humor Proteome in RVO-Associated Macular Edema: Analysis during Three Consecutive Conbercept Treatments. [PDF]
ACS OmegaPurpose: This exploratory study aimed to assess the aqueous humor (AH) proteome in patients with retinal vein occlusion (RVO) and macular edema (ME) receiving three consecutive intravitreal injections of Conbercept, to identify potential molecular ...
Liu S +8 more
europepmc +2 more sources
Intraocular pressure effect of intravitreal conbercept injection for retinopathy of prematurity [PDF]
Frontiers in Pharmacology, 2023 Purpose: Intravitreal injection of conbercept (IVC) is a novel anti-vascular endothelial growth factor (anti-VEGF) treatment for retinopathy of prematurity (ROP). This study aimed to assess the intraocular pressure (IOP) effect of IVC.Methods: All IVC surgeries were performed in the Department of Ophthalmology, Guangdong Women and Children Hospital ...
Caifeng Gao +10 more
openaire +5 more sources
Effect of Adjuvant Conbercept on Patients with Macular Edema Induced by Diabetic Retinopathy and Retinal Vein Occlusion Undergoing Laser Treatment: Impact on Symptom Improvement. [PDF]
Int J Gen MedObjective To evaluate the effect of adjuvant Conbercept in patients with macular edema caused by diabetic retinopathy (DR) or retinal vein occlusion (RVO) undergoing laser therapy, and its impact on symptom improvement.
Cai L, Wang J, Huang D, Cai Z.
europepmc +2 more sources
Renal dysfunction associated with clinical response to intravitreal conbercept therapy for diabetic macular edema. [PDF]
Int J OphthalmolAIM To investigate the impact of renal dysfunction on clinical response to intravitreal conbercept injection (IVC) for diabetic macular edema (DME). METHODS This retrospective study included a total of 100 eyes from 100 patients with DME treated with ...
Wu W +7 more
europepmc +2 more sources
Effect of multiple intravitreal injections of conbercept on the cornea in patients with branch retinal vein occlusion-induced macular edema. [PDF]
Front Med (Lausanne)Background To investigate the effect of multiple intravitreal injections of conbercept on the cornea in patients with branch retinal vein occlusion (BRVO)-induced macular edema.
Zhai G, Shen T, Su Y, Liu N.
europepmc +2 more sources
Profile of conbercept in the treatment of neovascular age-related macular degeneration [PDF]
Drug Design, Development and Therapy, 2015 In developed countries, age-related macular degeneration (AMD) is the leading cause of irreversible blindness in individuals over the age of 65 years. Vascular endothelial growth factor (VEGF) plays a vital role in the formation of neovascular AMD.
Xiaodong Sun, Xinmin Lu
core +5 more sources
Fusion proteins for treatment of retinal diseases: aflibercept, ziv-aflibercept, and conbercept [PDF]
International Journal of Retina and Vitreous, 2016 In the last few years, monoclonal antibodies have revolutionized the treatment of retinal neovascular diseases. More recently, a different class of drugs, fusion proteins, has provided an alternative treatment strategy with pharmacological differences.
João Rafael de Oliveira Dias +4 more
openaire +4 more sources
Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy [PDF]
Journal of Ophthalmology, 2018 Introduction. To compare the effect and safety of intravitreal conbercept (IVC), intravitreal ranibizumab (IVR), or intravitreal triamcinolone acetonide (IVTA) injection on 23-gauge (23-G) pars plana vitrectomy (PPV) for proliferative diabetic ...
Jinglin Cui +8 more
doaj +2 more sources
Anti-scarring effects of conbercept on human Tenon’s fibroblasts: comparisons with bevacizumab
BMC Ophthalmology, 2023 Background Safely inhibiting the formation of scar in the glaucoma filtration surgery (GFS) has always been an issue for clinical glaucoma doctors. Anti-vascular endothelial growth factor (VEGF) agents can reduce angiogenesis, and anti-placental growth ...
Lei Zuo +3 more
doaj +3 more sources